Skip to content
healthcare.dev

Clopidogrel bisulfate

NDC 55111-671, Clopidogrel bisulfate, tablet, film coated, from Dr.Reddy's Laboratories Limited.

Product NDC
55111-671
Status
Listed
Labeler
Dr.Reddy's Laboratories Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091023
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55111-671 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLOPIDOGREL BISULFATE300 mg/1

Pharmacologic classes

Cytochrome P450 2C8 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
55111-671-0155111067101100 TABLET, FILM COATED in 1 BOTTLE (55111-671-01)
55111-671-0555111067105500 TABLET, FILM COATED in 1 BOTTLE (55111-671-05)
55111-671-305511106713030 TABLET, FILM COATED in 1 BOTTLE (55111-671-30)
55111-671-31551110671315 BLISTER PACK in 1 CARTON (55111-671-31) / 6 TABLET, FILM COATED in 1 BLISTER PACK (55111-671-06)
55111-671-48551110671481 BLISTER PACK in 1 CARTON (55111-671-48) / 4 TABLET, FILM COATED in 1 BLISTER PACK
55111-671-785511106717810 BLISTER PACK in 1 CARTON (55111-671-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-671-79)
55111-671-81551110671813 BLISTER PACK in 1 CARTON (55111-671-81) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-671-79)
55111-671-905511106719090 TABLET, FILM COATED in 1 BOTTLE (55111-671-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4da4da53-91ae-4d4f-145f-255c5db443a5
  • NADAC price for package 55111067131

    GET /v1/drugs/nadac/55111067131

Use it

Look up 55111-671 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55111-671 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55111-671. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.